Chronic Myeloproliferative Disorders Active Not Recruiting Phase 2 / 3 Trials for Busulfan (DB01008)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)Active Not Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00003816Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic CancerTreatment